Abstract
Common colds were shortened by 7 days in a 1984 clinical trial using zinc gluconate throat lozenges each 2 h. Between then and 2004, 10 other double-blind, placebo-controlled clinical trials showed widely varying results. This re-analysis of these trials presents solution chemistry methods to elucidate differences in efficacy. Statistically significant correlation was shown between total daily dosages of positively charged zinc species and reductions in median (p = 0.005) and mean duration (p < 0.02) of common colds in these trials.
Keywords: Zinc, zinc gluconate, zinc acetate, zinc lozenges, common cold, rhinovirus
REFERENCES
- 1.Winther B., Gwaltney J. M., Mygind N., Turner R. B., Hendley J. O. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA. 1986;256:1763–1767. [PubMed] [Google Scholar]
- 2.Eby G. A., Davis D. R., Halcomb W. W. Reduction in duration of common colds by zinc gluconate lozenges in a double blind study. Antimicrob. Agents Chemother. 1984;25:20–24. doi: 10.1128/aac.25.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Al-Nakib W., Higgins P. G., Barrow I., Batstone G., Tyrell D. A. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J. Antimicrob. Chemother. 1987;20:893–901. doi: 10.1093/jac/20.6.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Eby, G. A. (1994) Handbook for Curing the Common Cold-The Zinc Lozenge Story, George Eby Research, Austin (http://coldcure.com/html/handbook-for-curing-the-common-cold.html).
- 5.Eby G. A. Zinc ion availability-the determinant of efficacy in zinc lozenge treatment of common colds. J. Antimicrob. Chemother. 1997;40:483–493. doi: 10.1093/oxfordjournals.jac.a020864. [DOI] [PubMed] [Google Scholar]
- 6.Eby G. A. The Zinc lozenge and common cold story. In: Metal-Ligand Interactions in Biological Fluids: Bioinorganic Medicine, Vol. 2. New York: Marcel Dekker, Inc.; 1995. pp. 1182–1190. [Google Scholar]
- 7.Bakar N. K. A., Taylor D. M., Williams D. R. The chemical speciation of zinc in human saliva: possible correlation with reduction of the symptoms of the common cold produced by zinc gluconate-containing lozenges. Chem. Speciat. Bioavailab. 1999;11:95–101. [Google Scholar]
- 8.Jackson J. L., Lesho E., Peterson C. Zinc and the common cold: a meta-analysis revisited. J. Nutr. 2000;130:1512S–1515S. doi: 10.1093/jn/130.5.1512S. [DOI] [PubMed] [Google Scholar]
- 9.Jackson J. L., Peterson C., Lesho E. A meta-analysis of zinc salts lozenges and the common cold. Arch. Int. Med. 1997;157:2373–2376. doi: 10.1001/archinte.157.20.2373. [DOI] [PubMed] [Google Scholar]
- 10.Macknin M. L. Zinc Lozenges for the common cold. Cleve. Clin. J. Med. 1999;66:27–32. doi: 10.3949/ccjm.66.1.27. [DOI] [PubMed] [Google Scholar]
- 11.Korant B. D., Kaurer J. C., Butterworth B. E. Zinc ions inhibit replication of rhinoviruses. Nature. 1974;248:588–590. doi: 10.1038/248588a0. [DOI] [PubMed] [Google Scholar]
- 12.Prasad A. S., Fitzgerald J. T., Bao B., Beck F. W. J., Chandrasekar P. H. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. a randomized, double-blind, placebo-controlled trial. Ann. Int. Med. 2000;133:245–252. doi: 10.7326/0003-4819-133-4-200008150-00006. [DOI] [PubMed] [Google Scholar]
- 13.Pasternak C. A. A novel form of host defense: membrane protection by calcium and zinc ions. Biosci. Rep. 1987;7:81–91. doi: 10.1007/BF01121871. [DOI] [PubMed] [Google Scholar]
- 14.Novick S. G., Godfrey J. C., Pollack R. L., Wilder H. R. Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants. Med. Hypotheses. 1997;49:347–357. doi: 10.1016/s0306-9877(97)90201-2. [DOI] [PubMed] [Google Scholar]
- 15.Taylor D. M., Williams D. R. Trace Element Medicine and Chelation Therapy. Cambridge: The Royal society of Chemistry; 1995. p. 63. [Google Scholar]
- 16.Martell A. E., Motekaitis R. J. Determination and Use of Stability Constants. Weinheim, Germany: VCH; 1988. [Google Scholar]
- 17.Pettit L. D., Powell K. J. The IUPAC Stability Constants Database. Otley, UK: Academic Software; 1997. [Google Scholar]
- 18.Smith R. M., Martell A. E., Motekaitis R. J. NIST Critically Selected Stability Constants of Metal Complexes Database, Version 2. Gaithersburg, MD: US Department of Commerce, NIST; 1995. [Google Scholar]
- 19.Cannan R. K., Kibrick A. Complex formation between carboxylic acids and divalent metal cations. Am. Chem. Soc. 1938;60:2314–2320. [Google Scholar]
- 20.Smith D. S., Helzner E. C., Nuttall C. E. J., Collins M., Rofman B. A., Ginsberg D., Goswick C. B., Magner A. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob. Agents Chemoth. 1989;33:646–648. doi: 10.1128/aac.33.5.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Weismann K., Jakobsen J. P., Weismann J. E., Hammer U. M., Nyholm S. M., Hansen B., Lombolt K. E., Schmidt K. Zinc gluconate for common cold. Dan. Med. Bull. 1990;37:279–281. [PubMed] [Google Scholar]
- 22.Godfrey J. C., Conant Sloane B., Smith D. S. Zinc gluconate and the common cold. J. Int. Med. Res. 1992;20:234–246. doi: 10.1177/030006059202000305. [DOI] [PubMed] [Google Scholar]
- 23.Alemdaroglu T., Berthon G. Trace metal requirements in total parenteral nutrition II. Potentiometric study of the metal-ion equilibria in the zinc-histidine, zinc-glycine, zinc-cysteine-histinidine, zinc-glycine-histidine and zinc-glycine-cysteine systems under physiological conditions. J. Electroanal. Chem. and Interfacial Electrochem. 1981;128:49–62. [Google Scholar]
- 24.Mossad S. B., Macknin M. L., Medendrop S. V., Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann. Int. Med. 1996;125:81–88. doi: 10.7326/0003-4819-125-2-199607150-00001. [DOI] [PubMed] [Google Scholar]
- 25.Macknin M. L., Piedmonte M., Calendine C., Janosky W. E. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA. 1998;279:1962–1967. doi: 10.1001/jama.279.24.1962. [DOI] [PubMed] [Google Scholar]
- 26.Turner R. B., Cetnarowski W. E. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin. Infect. Dis. 2000;31:1202–1208. doi: 10.1086/317437. [DOI] [PubMed] [Google Scholar]
- 27.McElroy B. H., Miller S. P. Effectiveness of zinc gluconate glycine lozenges (Cold-Eeze_) against the common cold in school-aged subjects: a retrospective chart review. Am. J. Ther. 2002;9:472–475. doi: 10.1097/00045391-200211000-00002. [DOI] [PubMed] [Google Scholar]
- 28.Eby G. A. Cold-Eeze lozenge for common colds. Am. J. Ther. 2003;10:233. doi: 10.1097/00045391-200305000-00012. [DOI] [PubMed] [Google Scholar]
- 29.Hacht B., Berthon G. Metal ion-FTS nonapeptide interactions. A quantitative study of zinc(II)-nonapeptide complexes (thymulin) under physiological conditions and assessment of their biological significance. Inorganica. Chimica. Acta. 1987;136:165–171. doi: 10.1016/S0020-1693(00)81149-4. [DOI] [Google Scholar]
- 30.Petrus E. J., Lawson K. A., Bucci L. R., Blum K. Randomized, double-masked, placebocontrolled, clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr. Ther. Res. 1998;59:595–607. doi: 10.1016/S0011-393X(98)85058-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Farr B. M., Conner E. M., Betts R. F., Oleske J., Minnefor A., Gwaltney J. M. J. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob. Agents Chemother. 1987;31:1183–1187. doi: 10.1128/aac.31.8.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Martin R. B. pH as a variable in free zinc ion concentration from zinc-containing lozenges. Antimicrob. Agents and Chemother. 1988;32:608–609. doi: 10.1128/aac.32.4.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Douglas R. M., Miles H. B., Moore B. W., Ryan P., Pinnock C. B. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob. Agents Chemother. 1987;31:1263–1265. doi: 10.1128/aac.31.8.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Berthon G., Varsamidis A., Blaquiere C., Rigal D. Histamine as a ligand in blood plasma. Part 7. Malate, malonate, maleate and tartrate as adjuvants of zinc to flavor histamine tissue diffusion through mixed-ligand coordination. In vitro tests on lymphocyte proliferation. Agents Actions. 1987;22:231–247. doi: 10.1007/BF02009051. [DOI] [PubMed] [Google Scholar]
- 35.Eby G. A. Elimination of efficacy by additives in zinc acetate lozenges for common colds. Clin. Infect. Dis. 2001;32:1520. doi: 10.1086/320177. [DOI] [PubMed] [Google Scholar]
- 36.Bhutta Z. A., Black R. E., Brown K. H., Gardner J. M., Gore S., Hidayat A., Khatun, Martorell F. R., Ninh N. X., Penny M. E., Rosado J. L., Roy S. K., Ruel M., Sazawal S., Shankar A. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J. Pediatr. 1999;135:689–697. doi: 10.1016/s0022-3476(99)70086-7. [DOI] [PubMed] [Google Scholar]
- 37.Duchateau J., Delepesse G., Vrijens R., Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am. J. Med. 1981;70:1001–1004. doi: 10.1016/0002-9343(81)90849-4. [DOI] [PubMed] [Google Scholar]
- 38.Duchateau J., Delespesse G., Vereecke P. Influence of oral zinc supplementation on the lymphocyte response of mitogens of normal subjects. Am. J. Clin. Nutr. 1981;34:88–93. doi: 10.1093/ajcn/34.1.88. [DOI] [PubMed] [Google Scholar]
- 39.Chandra R. K. Excessive intake of zinc impairs immune responses. JAMA. 1984;252:1443–1446. [PubMed] [Google Scholar]
- 40.Turner R. B. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin. Infect. Dis. 2001;33:1865–1870. doi: 10.1086/324347. [DOI] [PubMed] [Google Scholar]
- 41.Nordenstrém B. E. Biologically Closed Electric Circuits. Clinical, Experimental and Theoretical Evidence for an Additional Circulatory System. Stockholm: Nordic Medical Publications; 1983. [Google Scholar]
- 42.Franklin, P. (1931) Treatment of hay fever by intranasal zinc ionization. BMJ 1115–1116.
- 43.Merck . Manual of the Materia Medica. Merck, New York: Formulas; 1901. p. 125. [Google Scholar]
- 44.Tisdall F. F., Brown A., Defries R. D. Persistent anosmia following zinc sulphate nasal spraying. J. Pediatr. 1938;13:60–62. [Google Scholar]
- 45.Hirt M., Nobel S., Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial. ENT. 2000;79:778–80. [PubMed] [Google Scholar]
- 46.Mossad S. B. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM. 2003;96:35–43. doi: 10.1093/qjmed/hcg004. [DOI] [PubMed] [Google Scholar]
- 47.DeCook C. A., Hirsch A. R. Anosmia due to inhalational zinc: a case report. Chem Senses. 2000;25:659. [Google Scholar]
- 48.Arens M., Travis S. Zinc salts inactivate clinical isolates of herpes simplex virus in vitro. J.Clin. Microbiol. 2000;38:1758–1762. doi: 10.1128/jcm.38.5.1758-1762.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Eby G. A., Halcomb W. W. Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols. Med. Hypotheses. 1985;17:157–165. doi: 10.1016/0306-9877(85)90142-2. [DOI] [PubMed] [Google Scholar]
- 50.Briggs J., Finch P., Matulewicz M. C., Weigel H. Complexes of copper(II), calcium, and other metal ions with carbohydrates: thin-layer ligand-exchange chromatography and determination of relative stabilities of complexes. Carbohydr. Res. 1981;97:181–188. doi: 10.1016/S0008-6215(00)80664-3. [DOI] [Google Scholar]